MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain
· Source: tradingview.com
In short
MetaTech AP announced its growth strategy for 2027 emphasizing expansion in AI supply chain and regenerative medicine. It reported a 21% revenue increase in 2026 and formed a partnership with Zheng Yang Biomedical to enhance cell culture materials production and market regenerative medicine products globally, including advancing a dry eye disease treatment. MetaTech AP aims to establish Taiwan as a regenerative medicine manufacturing hub leveraging AI-driven technologies.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 42, 2026: Planning AI reaches a quantified milestone as Cencora reports 10% forecast improvement
Tags: regenerative, medicine, supply, chain, AI, manufacturing